跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
思力华 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tiotropium Bromide Powder for Inhalation
Approved
化学药品
Tiotropium Bromide Powder for Inhalation
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
May 13, 2024
Approval ID
8aKPrUIidAJ
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8aKPrUIidAJ
Approval Number
国药准字HJ20140954
Generic Name
噻托溴铵吸入粉雾剂
Generic Name En
Tiotropium Bromide Powder for Inhalation
Trade Name
思力华
Drug Type
化学药品
Dosage Form
吸入粉雾剂
Strength
每粒含噻托溴铵18μg(按C₁₉H₂₂NO₄S₂计),递送剂量为10.2μg(按 C₁₉H₂₂NO₄S₂计)
Reg Date
2024-05-13
Expired Date
2029-05-12
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 13, 2024
Approval ID
8aKPrUIidAJ
Type
化学药品
Back to NMPA Approvals